Methoxphenidine
http://dbpedia.org/resource/Methoxphenidine an entity of type: Thing
Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relatio
rdf:langString
rdf:langString
Methoxphenidine
xsd:integer
41255861
xsd:integer
1099858799
xsd:integer
20
xsd:integer
127529
xsd:integer
52085156
xsd:integer
25
xsd:integer
-1
rdf:langString
NpSG
rdf:langString
Illegal in China and Sweden
rdf:langString
PSA
xsd:integer
1
xsd:integer
1
xsd:integer
67833251
rdf:langString
Oral, Rectal
rdf:langString
COC1=CCN3CCCCC3
xsd:integer
1
rdf:langString
QXXCUXIRBHSITD-UHFFFAOYSA-N
rdf:langString
H2W7A6GZGX
rdf:langString
Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relationship shared by the arylcyclohexylamines.
rdf:langString
Schedule I
xsd:nonNegativeInteger
10107
xsd:string
127529-46-8
xsd:string
H2W7A6GZGX
xsd:string
67833251